Igenica Biotherapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.igenica.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AML
- First Posted Date
- 2014-01-20
- Last Posted Date
- 2016-02-23
- Lead Sponsor
- Igenica Biotherapeutics, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT02040506
- Locations
- 🇺🇸
UCSD Medical Center / Thornton Hospital, La Jolla, California, United States
🇺🇸Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
🇺🇸Indiana Blood and Marrow Transplantation Clinic, Indianapolis, Indiana, United States
News
No news found